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thrombus aspiration with the Rescue PT catheter (Rescue) prior to stenting (both primary
stenting and stenting with predilation) in AMI patients. Method: Inclusion criteria were 1)
within 24 hours from onset, 2) lesion diameter > 2.5mm, 3) no severe calcification at or
proximal to the lesion, 4) no proximal tortuosity preventing Rescue use or stent delivery,
5) no cardiogenic shock, 6) no left main disease. In this mid-trial analysis, 258 patients
have been enrolled so far; 129 patients were assigned to primary stenting (Group P,
65.9+/- 11.1, 103 male) and 129 to stenting after Rescue (Group R, 64.0 +/- 11.8, 103
male), 5 were excluded. Results: In Group R, Rescue successfully crossed the culprit
lesion in 99 patients (76.7%) and successful thrombus aspiration was achieved in 90
patients (69.8%). There were no complications with the use of Rescue. However, there
was no significant difference in final TIMI III grade flow between the two groups. Conclu-
sion; Rescue could be safely used with AMI patients. This study did not show the efficacy
of Rescue in providing a protective effect against no-reflow or slow flow phenomena in
reperfusion therapy.
1003-86 Percutaneous Coronary Intervention With Distal 
Protection Device Preserves Left Ventricular Function 
in Patients With Acute Anterior Myocardial Infarction
Tomohiro Nakamura, Norifumi Kubo, Nahoko Ikeda, Takeshi Ishida, Hiroshi Funayama, 
Shigemasa Hashimoto, Takanori Yasu, Muneyasu Saito, Jichi Medical School Omiya 
Medical Center, Saitama, Japan
Background: Angiographic no-reflow phenomenon during percutaneous coronary inter-
vention (PCI) is one of poor prognostic factors in patients with acute myocardial infarction
(AMI). The aim of this study is to evaluate the effects of occlusive balloon type distal pro-
tection device (PercuSurge GuardWire®; GW) during primary stentÅ@implantation in
patients with AMI. Methods: We studied consecutive 72 patients with anterior AMI treated
by primary stent implantation. GW group included 42 patients treated by primary stent
implantation with GW protection. Control group included 30 patients trearted by primary
stent implantation after thrombectomy without distal protection. The corrected TIMI frame
count (cTFC) and myocardial blush grade (MBG) after PCI were assessed. Left ventricu-
lar (LV) function was measured and compared by left ventriculography obtained at soon
after PCI and three weeks after onset. Results: Clinical baseline characteristics were
similar between the two groups. The cTFC were lower in GW group than in control group
(27.5 ± 2.3 vs. 35.1 ± 2.5, P = 0.030). Patient numbers of MBG 3 after PCI were higher in
GW group than in control group (45.7 vs. 20.0 %, P = 0.029). Peak creatinine kinase
myocardial fraction level was lower in GW group than in control group (326.6 ± 41.5 vs.
454.9 ± 46.2 mg/dl, P = 0.043). GW group patients showed greater improvement at 3
weeks after PCI in left ventricular ejection fraction (+4.6 ± 1.2 vs. -1.1 ± 1.5, P = 0.004)
and in left ventricular end-systolic volume index (+0.5 ± 2.4 vs. +9.0 ± 2.7, P = 0.023) and
in regional wall motion abnormalities (-2.03 ± 0.14 vs. -2.51 ± 0.14, P = 0.018). Concul-
sion: PCI with GW protection could not only restore epicardial coronary flow and myocar-
dial perfusion, but also preserve left ventricular function in anterior AMI.
1003-87 Reperfusion Time-Dependent Myocardial Salvage in 
Patients With Acute Myocardial Infarction Who Undergo 
Emergent Percutaneous Coronary Intervention With 
Distal Protection Device PercuSurge
Hiroaki Mukawa, Takahito Sone, Hideyuki Tsuboi, Itsuro Morishima, Masahiko Satoda, 
Michitaka Uesugi, Ogaki Municipal Hospital, Ogaki, Japan
Purpose; Time-dependent myocardial salvage demonstrated in the experimental animal
model is rarely observed in clinical settings. The distal embolism and the microcirculation
injury caused by PCI itself may be attributed to this discrepancy. We investigated the
impact of distal protection during emergent PCI on myocardial salvage and the relation-
ship between reperfusion time and myocardial salvage in patients with acute myocardial
infarction.
Method; Patients with acute myocardial infarction were immediately treated by oral aspi-
rin and intravenous heparin, and underwent PCI with distal protection using PercuSurge
(P group; n=32) or without distal protection (C group; n=190). Risk area and infarct area
were assessed by radionuclide ventriculography using quantitative perfusion SPECT
(QPS), and myocardial salvage volume (risk area-infarct area) and salvage index (myo-
cardial salvage / risk area) were calculated.
Results; TIMI 3 flow at first angiogram was observed in 7.4% in P group and in 18.8% in
C group. PCI was performed successfully in all patients. Stent was implanted in 75.8%,
83.3%, respectively. Reperfusion time in P group was significantly longer than in C group
(405.2 vs. 218.2 min, respectively). There were not significant differences in risk area, inf-
arct area and myocardial salvage volume between both groups. However, salvage index
was higher in P group despite of longer reperfusion time (67.3% in P group vs. 62.6% in
C group, not significantly). Moreover, significant correlation between reperfusion time and
salvage index was observed in P group (R=0.604, P=0.036), but only tendency was
observed in C group.
Conclusion; Distal protection during emergent PCI may reduce myocardial damage
caused by PCI itself and achieve clearly time-dependent myocardial salvage.
1003-88 Impact of Angioplasty With Distal Protection Device on 
Myocardial Reperfusion
Mamoru Nanasato, Haruo Hirayama, Takashi Muramatsu, Kazumasa Unno, Masayuki 
Shimano, Kunihiro Matsushita, Hiroto Takezawa, Mitsuhiro Yokota, Toyoaki Murohara, 
Nagoya Daini Red Cross Hospital, Nagoya, Japan, Nagoya University, Nagoya, Japan
Background: Several studies have shown that distal embolization plays an important
role in causing reduced coronary flow and impaired microcirculatory function in patients
with acute myocardial infarction (AMI) treated with percutaneous coronary intervention
(PCI). However, there is little information on the efficacy of a distal protection device as
an adjunctive therapy to PCI in patients with AMI.
Methods: Patients within 12 hours after the onsets of AMI were enrolled. Of 64 eligible
patients, 34 were randomly assigned to PCI with a distal protection device, GuardWire
Plus as a reperfusion therapy, and 30 were assigned to conventional PCI. Patients were
evaluated by coronary angiography and electrocardiography at admission, and thallium-
201 myocardial scintigraphy before discharge. Thallium-201 myocardial scintigraphy cal-
culated left ventricular ejection fraction (LVEF) and area of myocardial infarction as sever-
ity score. All patients gave written informed consent.
Results: Baseline data were similar in both groups. Postprocedural thrombolysis in myo-
cardial infarction (TIMI) 3 flow was obtained in all patients treated with PCI plus distal pro-
tection device, and in 92% of conventional PCI (NS). However, patients treated with PCI
plus distal protection device had significantly lower corrected TIMI frame count on the
postprocedural coronary angiography (23.7 ± 10.3 vs. 33.7 ± 20.6; p=0.04), significantly
higher occurrence of grade 3 myocardial blush (71% vs. 35%; p=0.02) and early ST-seg-
ment elevation resolution on electrocardiography (79% vs. 50%; p=0.03), significantly
higher LVEF on thallium-201 myocardial scintigraphy (51.2 ± 14.5% vs. 46.7 ± 12.2%;
p=0.02), and lower severity score (5.6 ± 6.3 vs. 10.3 ± 7.3; p=0.01).
Conclusions: Use of this distal protection device during PCI in patients with AMI was
associated with a significant improvement of coronary reperfusion compared with con-
ventional PCI. This demonstrates the value of this distal protection device to obtain better
coronary reperfusion and that the reperfusion therapy with the distal protection device
may preserve left ventricular function in patients with AMI.
1003-89 Angiographic No-Reflow Phenomenon in the Patients 
With Acute Myocardial Infarction After Percutaneous 
Transluminal Coronary Intervention
Masayoshi Oikawa, Nobuo Komatsu, Yoshitaka Shiratori, Hiroyuki Kunii, Hidetsugu 
Yamao, Shigeto Namiuti, Masafumi Sugi, Mitsuru Yui, Toshikatsu Ichihara, Yukio 
Maruyama, Iwaki Kyouritsu General Hospital, Iwaki, Japan, Fukushima Medical 
University, Fukushima, Japan
Purpose: In this retrospective study, we investigated the incidence of angiographic no-
reflow or slow flow phenomenon (no-reflow) after percutaneous transluminal coronary
intervention (PCI) in patients with acute myocardial infarction (AMI).Method : We studied
425 consecutive patients with AMI treated by PCI during the period of January, 1998 to
May, 2002.Left main disease was excluded. The patients were categorized as follows:
Group P-270 patients which were performed PCI without thrombus aspiration; Group T-
155 patients which were performed PCI after thrombus aspiration using the Rescue PT
catheter.Results: The incidence of no-reflow was 44 of 425 (10.3%).There was no signifi-
cant difference in the incidence of no-reflow between the two groups (table).Conclu-
sion:In this study,the protectve effect of thrombus aspiration against no-reflow was not
proven.
P group (N=129) R group (N=129) p value
Infarct-related vessel
LAD
LCX
RCA
59 (45.8%)
15 (11.6%)
55 (42.6%)
44 (34.1%)
21 (16.3%)
64 (49.6%)
N.S.
Final TIMI grade
III
II
< or =I
119 (92.2%)
 10 (7.8%)
 0
121 (93.8%)
 8 (6.2%)
 0
N.S.
peak CPK (IU/L)
total
LAD
LCX
RCA
2560 +/- 2119
3067 +/- 2596
2741 +/- 1690
1984 +/- 1504
2608 +/- 2818
2966 +/- 3715
2901 +/- 2735
2154 +/- 1538
N.S.
N.S.
N.S.
N.S.
In-hospital death 2 (1.6%) 2 (1.6%) N.S.
Table
Group P Group T p value
No. of pts 270 155 NS
age 66+/-11 63+/-12 NS
sex (male%) 71% 76% NS
Infarct-related vessel
LAD
LCX
RCA
122
50
98
62
27
66
NS
Final TIMI grade
TIMI<or=II
TIMI III
29 (10.8%)
241 (89.2%)
15 (9.7%)
140 (90.3%)
NS
Peak CPK (IU/L) 2355+/-2482 2962+/-2128 0.001
In-hospital death 17 (6.3%) 6 (3.9%) NS
